These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24813411)

  • 21. Olanzapine and olanzapine-fluoxetine combination treatment and bipolar I depression.
    Williams AB; Adetunji BA
    Arch Gen Psychiatry; 2005 Sep; 62(9):1052; author reply 1052. PubMed ID: 16143737
    [No Abstract]   [Full Text] [Related]  

  • 22. Newer treatment studies for bipolar depression.
    Gao K; Calabrese JR
    Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
    Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
    J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
    [No Abstract]   [Full Text] [Related]  

  • 25. [Second generation antipsychotics in bipolar depression: a new therapeutic option?].
    Llorca PM
    Encephale; 2011 Dec; 37 Suppl 3():S209-13. PubMed ID: 22212877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
    Nair SS; Chua CJM; Teo DCL
    East Asian Arch Psychiatry; 2021 Sep; 31(3):81-83. PubMed ID: 34588318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
    Med Lett Drugs Ther; 2004 Mar; 46(1178):23-4. PubMed ID: 15037858
    [No Abstract]   [Full Text] [Related]  

  • 31. Typical and atypical antipsychotics in bipolar depression.
    Gao K; Gajwani P; Elhaj O; Calabrese JR
    J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the efficacy of treatments for bipolar depression.
    Nierenberg AA
    J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
    Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].
    Bánki CM
    Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.